Effect of ayurvedic drug Divya Trighan in patients with increased uric acid.
Phase 3
- Conditions
- Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
- Registration Number
- CTRI/2023/07/055433
- Lead Sponsor
- Patanjali Research Institute governed by Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. The subject with raised uric acid level in blood or urine (male: = 8.5 mg/dl and female = 7.3mg/dl)
2. Males or Females of age limit 18 to 60 years.
3. Patient agrees to provide informed consent.
4. Patient willing to participate in the study and ready to comply with study protocols.
5. No alcohol or drug dependency.
Exclusion Criteria
1. Pregnancy or lactation, intent to become pregnant.
2. The subject with complications of pre-existing comorbidities or surgical intervention or undergone dialysis in last 3 month.
3. The subject with known history of uncontrolled DM and HTN.
4. The subject not willing to provide consent.
5. The subject not willing to comply with the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the change in Uric acid levels after treatment with Divya Trighan in patients with Hyperuricemia.Timepoint: Baseline, 4 weeks, 8 weeks
- Secondary Outcome Measures
Name Time Method •Change in the Quality of life of patients with SF-36 questionnaireTimepoint: day 1,day 30,day 60